SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Myriad Genetics, Inc. (MYGN)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
2355 65 0 MYGN
Emcee:  s myers Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2005Yeah, Myriad owns a huge chunk that will come down to a very small chunk, given scaram(o)uche-6/12/2007
2004Rick, Thanks for posting that. They are doing some very interesting stuff... LJM-6/12/2007
2003Prolexys Pharmaceuticals, Inc. From Tech Gurus to Cancer Drug Pioneers By Janescaram(o)uche-6/12/2007
2002Myriad Genetics Presents Mathematical Comparison of Disease Modification Trial DA.J. Mullen-6/11/2007
2001On The Cover/Top Stories Will You Get Cancer? Matthew Herper and Robert LangrethExCane-6/1/2007
2000Epigenomics AG Enters Into R&D Collaboration With Myriad Genetics Inc. to Discaram(o)uche-5/15/2007
1999United States Patent 7,202,329 Wettstein , et al. April 10, 2007 -------scaram(o)uche-5/15/2007
1998Teflon Meldrum, over-promise, under-deliver..... myriad.com Down to seven scaram(o)uche-5/15/2007
1997$4 Trillion in Cost Savings to U.S. From New Disease-Modifying Alzheimer's Tsim1-5/15/2007
1996They're back to being a cancer company, I guess???..... Prolexys Pharmaceutscaram(o)uche-5/13/2007
1995Okay - sorry for delay in my response. Appreciate the answers, and the word &quenigma7-5/7/2007
1994gotcha, thanks, Harry. Rickscaram(o)uche-5/3/2007
1993Rick: Allon hits me in my 'sympathy for the underdog' weak spot, and myNeuroInvestment-5/3/2007
1992Thanks. Was going to pop into valuation thread with a pointer for you. You'scaram(o)uche-5/3/2007
1991The comparison to Myriad seems absurd, other than there is a mutual interest in NeuroInvestment-5/3/2007
1990While at Biofinance last week in Canada, I heard a number of analysts compare a enigma7-5/2/2007
1989Myriad Genetics Reports Results for Third Quarter of Fiscal 2007 80% Gross Profimopgcw-5/2/2007
1988Myriad Genetics Presents Tumor Origin Technology at AACR Wednesday April 18, 6:3nigel bates-4/18/2007
1987Myriad Genetics Presents Azixa's Mode of Action at AACR Tuesday April 17, 6:nigel bates-4/17/2007
1986PM, T2D...... Message 23459428scaram(o)uche-4/15/2007
1985United States Patent 7,202,329 Wettstein , et al. April 10, 2007 -------scaram(o)uche-4/10/2007
1984United States Patent 7,195,873 Filigheddu , et al. March 27, 2007 ------scaram(o)uche-3/27/2007
1983Myriad Genetics Completes Enrollment in Second Phase 3 Clinical Trial of Flurizasim1-3/20/2007
1982Maybe the Caymens? -g- Hopefully, the upcoming cancer confabs will give us somzeta1961-3/13/2007
1981Management must think they are big pharma. No need to report on a phase 1? I hkenhott-3/13/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News